Background
The combination of ataxia and hypogonadism was first described more than a
century ago, but its genetic basis has remained elusive.
Methods
We performed whole-exome sequencing in a patient with ataxia and hypogonadotropic
hypogonadism, followed by targeted sequencing of candidate genes in similarly
affected patients. Neurologic and reproductive endocrine phenotypes were
characterized in detail. The effects of sequence variants and the presence of an
epistatic interaction were tested in a zebrafish model.
Results
Digenic homozygous mutations in RNF216 and OTUD4, which encode a ubiquitin E3
ligase and a deubiquitinase, respectively, were found in three affected siblings in a
consanguineous family. Additional screening identified compound heterozygous
truncating mutations in RNF216 in an unrelated patient and single heterozygous
deleterious mutations in four other patients. Knockdown of rnf216 or otud4 in zebrafish
embryos induced defects in the eye, optic tectum, and cerebellum; combinatorial
suppression of both genes exacerbated these phenotypes, which were rescued by
nonmutant, but not mutant, human RNF216 or OTUD4 messenger RNA. All patients
had progressive ataxia and dementia. Neuronal loss was observed in cerebellar
pathways and the hippocampus; surviving hippocampal neurons contained ubiquitin-
immunoreactive intranuclear inclusions. Defects were detected
SI QUIERES VER ARTICULO COMPLETO VE AL SIGUIENTE LINK
http://www.nejm.org/doi/pdf/10.1056/NEJMoa1215993
Conclusions
The syndrome of hypogonadotropic hypogonadism, ataxia, and dementia can be
caused by inactivating mutations in RNF216 or by the combination of mutations in
RNF216 and OTUD4. These findings link disordered ubiquitination to neurodegeneration
and reproductive dysfunction and highlight the power of whole-exome sequencing
in combination with functional studies to unveil genetic interactions that
cause disease. (Funded by the National Institutes of Health and others.)
No hay comentarios:
Publicar un comentario